Fascioscapulohumeral muscular dystrophy
Clinical trials for Fascioscapulohumeral muscular dystrophy explained in plain language.
Never miss a new study
Get alerted when new Fascioscapulohumeral muscular dystrophy trials appear
Sign up with your email to follow new studies for Fascioscapulohumeral muscular dystrophy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Hope for FSHD: new drug enters final stage of testing
Disease control Recruiting nowThis phase 3 trial tests an experimental drug called AOC 1020 in 200 adults with facioscapulohumeral muscular dystrophy (FSHD), a genetic condition that causes progressive muscle weakness. Participants receive either the drug or a placebo by IV infusion. The study measures muscle…
Matched conditions: FASCIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
Phase 3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Shocking muscles to move: new exercise hope for nerve disease patients
Symptom relief Recruiting nowThis study tests whether whole-body electrical muscle stimulation (WB-EMS) can help adults with neuromuscular diseases like ALS, SMA, and muscular dystrophy exercise safely. Because these conditions weaken the nerves that control muscles, traditional exercise is often too hard. W…
Matched conditions: FASCIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
Sponsor: University of Missouri-Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC